Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.
Comprehensive Cancer Center Erlangen, European Metropolitan Region of Nuremberg, Erlangen, Germany.
J Cancer Res Clin Oncol. 2021 Jun;147(6):1763-1771. doi: 10.1007/s00432-020-03450-0. Epub 2020 Nov 21.
Uveal melanoma (UM) is an orphan cancer of high unmet medical need. Current patterns of care and surveillance remain unclear as they are situated in an interdisciplinary setting.
A questionnaire addressing the patterns of care and surveillance in the management of patients with uveal melanoma was distributed to 70 skin cancer centers in Austria, Germany and Switzerland. Frequency distributions of responses for each item of the questionnaire were calculated.
44 of 70 (62.9%) skin cancer centers completed the questionnaire. Thirty-nine hospitals were located in Germany (88.6%), three in Switzerland (6.8%) and two in Austria (4.5%). The majority (68.2%) represented university hospitals. Most patients with metastatic disease were treated in certified skin cancer centers (70.7%, 29/41). Besides, the majority of patients with UM were referred to the respective skin cancer center by ophthalmologists (87.2%, 34/39). Treatment and organization of follow-up of patients varied across the different centers. 35.1% (14/37) of the centers stated to not perform any screening measures.
Treatment patterns of patients with uveal melanoma in Germany, Austria and Switzerland remain extremely heterogeneous. A guideline for the treatment and surveillance is urgently needed.
葡萄膜黑色素瘤(UM)是一种罕见的高未满足医疗需求的癌症。由于其处于跨学科的环境中,当前的治疗和监测模式仍不清楚。
向奥地利、德国和瑞士的 70 个皮肤癌中心分发了一份关于葡萄膜黑色素瘤患者管理中治疗和监测模式的调查问卷。对调查问卷的每个项目的回答进行了频率分布计算。
70 个皮肤癌中心中有 44 个(62.9%)完成了调查问卷。39 家医院位于德国(88.6%),3 家位于瑞士(6.8%),2 家位于奥地利(4.5%)。大多数(68.2%)是大学医院。大多数转移性疾病患者在经过认证的皮肤癌中心接受治疗(70.7%,29/41)。此外,大多数 UM 患者由眼科医生转诊至相应的皮肤癌中心(87.2%,34/39)。不同中心的患者治疗和随访组织方式存在差异。35.1%(14/37)的中心表示不进行任何筛查措施。
德国、奥地利和瑞士的葡萄膜黑色素瘤患者的治疗模式仍然非常多样化。迫切需要制定治疗和监测指南。